[HTML][HTML] Venous thromboembolic events in the setting of extracorporeal membrane oxygenation support in adults: A systematic review

A Abruzzo, V Gorantla, SE Thomas - Thrombosis Research, 2022 - Elsevier
Extracorporeal membrane oxygenation (ECMO) is a form of prolonged mechanical
cardiopulmonary supportive therapy implemented for the survival of patients with refractory …

Antithrombin therapy: Current state and future outlook

GM Rodgers, A Mahajerin - Clinical and Applied Thrombosis …, 2023 - journals.sagepub.com
Antithrombin (AT) is a natural anticoagulant pivotal in inactivating serine protease enzymes
in the coagulation cascade, making it a potent inhibitor of blood clot formation. AT also …

Improving hemocompatibility and antifouling performance of polyethersulfone membrane by in situ incorporation of phosphorylcholine polymers

Y Du, X Chen, Y Mou, L Chen, X Li, J Wang, Y Shu… - Applied Surface …, 2024 - Elsevier
Hemodialysis (HD) is one of the most important treatments for patients suffering from kidney
failure, and polyethersulfone (PES) is the most common type of hemodialysis membrane …

[HTML][HTML] The role of nafamostat mesilate as a regional anticoagulant during extracorporeal membrane oxygenation

JH Lee, JH Park, JH Jang, SH Kim, SY Hong… - Acute and Critical …, 2022 - ncbi.nlm.nih.gov
Background Anticoagulation during extracorporeal membrane oxygenation (ECMO) usually
is required to prevent thrombosis. The aim of this study was to investigate the usefulness of …

[HTML][HTML] Anaesthesiologic Considerations for Intraoperative ECMO Anticoagulation During Lung Transplantation: A Single-Centre, Retrospective, Observational Study

J Vajter, G Holubova, R Novysedlak… - Transplant …, 2024 - frontierspartnerships.org
Extracorporeal membrane oxygenation (ECMO) is frequently used during lung
transplantation. Unfractionated heparin (UFH) is mainly used as part of ECMO support for …

Preparation and blood compatibility of polyethersulfone dialysis membrane modified by apixaban as coagulation factor Xa inhibitor

X Fu, T Lei, Y Xiao, C Tang - Biomaterials Advances, 2022 - Elsevier
Blood purification therapy is widely used in the treatment of critically ill patients. However,
most dialysis membranes are prone to thrombosis. Activated coagulation factor X (FXa) …

Clinical guidance for unfractionated heparin dosing and monitoring in critically ill patients

MN Samimi, A Hale, J Schults, A Fischer… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Unfractionated heparin is a widely used anticoagulant in critically ill patients. It
has a well-established safety profile and remains an attractive option for clinicians due to its …

[HTML][HTML] A Comprehensive Review of Extra Corporeal Membrane Oxygenation: The Lifeline in Critical Moments

S Geetha III, N Verma, V Chakole - Cureus, 2024 - ncbi.nlm.nih.gov
Extracorporeal membrane oxygenation (ECMO) has evolved into a pivotal intervention in
critical care, offering a lifeline for patients facing severe respiratory or cardiac failure. This …

Concurrent use of continuous kidney replacement therapy during extracorporeal membrane oxygenation: what pediatric nephrologists need to know—PCRRT …

R Raina, N Nair, J Pelletier, M Nied, T Whitham… - Pediatric …, 2024 - Springer
Extracorporeal membrane oxygenation (ECMO) provides temporary cardiorespiratory
support for neonatal, pediatric, and adult patients when traditional management has failed …

Anticoagulation Management in VV ECMO Patients: A Multidisciplinary Pragmatic Protocol

AB Rodrigues, A Rodrigues, CJ Correia… - Journal of Clinical …, 2024 - mdpi.com
(1) Background: Extracorporeal membrane oxygenation (ECMO) is a complex procedure
affecting both the risk of thrombosis and bleeding. High-quality data to personalize …